Becton, Dickinson and Co (BDX)
236.97
+6.19 (+2.68%)
USD |
NYSE |
Oct 04, 16:00
236.91
-0.06 (-0.03%)
Pre-Market: 20:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 67.58B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| All-Time High (Daily) | Upgrade |
| Year to Date Total Returns (Daily) | Upgrade |
| 1 Month Total Returns (Daily) | Upgrade |
| 1 Year Total Returns (Daily) | -0.14% |
| Valuation | |
| PE Ratio | 40.86 |
| PE Ratio (Forward) | Upgrade |
| PS Ratio | 3.306 |
| Price to Book Value | 2.651 |
| EV to EBITDA | Upgrade |
| Dividend | |
|---|---|
| Dividend | 0.87 |
| Dividend Yield (Forward) | Upgrade |
| Financials | |
| Revenue (5 Year Growth) | Upgrade |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (5 Year Growth) | Upgrade |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Debt to Equity Ratio | 0.6419 |
| Return on Equity | Upgrade |
| Return on Assets | Upgrade |
| Risk | |
| Beta (5Y) | Upgrade |
| Max Drawdown (5Y) | 29.62% |
News
Headline
Wire
Time (ET)
Yahoo
10/02 09:01
Yahoo
09/29 06:48
Yahoo
09/28 09:02
PR Newswire
09/27 06:50
Events
| DATE | TIME | TYPE | PERIOD | REPORTED EPS |
ESTIMATED EPS |
SURPRISE | |
| 11/04/2022* | -- | Results | Q4 2022 | -- | 2.74 | -- | |
| 11/04/2022* | 08:00 EST | Earnings Call | Q4 2022 | -- | -- | -- | |
| 08/04/2022 | 08:00 EST | Earnings Call | Q3 2022 | -- | -- | -- | |
| 08/04/2022 | -- | Results | Q3 2022 | 2.66 | 2.50 | 6.45% | |
| 05/05/2022 | -- | Results | Q2 2022 | 3.18 | 2.95 | 7.88% | |
| 05/05/2022 | 08:00 EST | Earnings Call | Q2 2022 | -- | -- | -- | |
| 02/03/2022 | -- | Results | Q1 2022 | 3.64 | 2.85 | 27.52% | |
| 02/03/2022 | 08:00 EST | Earnings Call | Q1 2022 | -- | -- | -- |
*Estimated Date/Time
Earnings
Profile
Edit
| Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Interventional (largely the former Bard business) accounts for 23% of revenue. International revenue accounts for 44% of the company's business. |
| URL | http://www.bd.com |
| Investor Relations URL | https://investors.bd.com/ |
| HQ State/Province | New Jersey |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Equity Style | Large Cap/Blend |
| Next Earnings Release | Nov. 04, 2022 (est.) |
| Last Earnings Release | Aug. 04, 2022 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Sep. 08, 2022 |
Analyst Coverage
|
Consensus Rating
|
|
|
Analyst Recommendation
|
|
Source: S&P Global
Dividends
| Dividend Per Share (TTM) | 3.44 |
|
2017
2018
2019
2020
2021
6.00%
4.00%
2.00%
|
|
| Yield to Market | 0.9998 |
| Yield to Sector | 0.7958 |
| Yield to Industry | 1.678 |
| Last Dividend Amt. | 0.87 |
| Dividend Frequency | Quarterly |
| Last Ex-Dividend Date | Sep. 08, 2022 |
| Yield (TTM) | 1.47% |
| Forward Yield | 1.47% |
| Payout Ratio | 60.99% |
| Cash Payout Ratio | 73.06% |
| Consistent Payer (5Y) |
|
| Consistent Growth (5Y) |
|
Risk Info
Total Returns Comparison
Annual Total Returns Versus Peers
As of October 04, 2022.
Fundamentals
| Revenue (TTM) | 20.61B |
| Total Expenses (TTM) | 17.50B |
| Net Income (TTM) | 1.756B |
| Total Assets (Quarterly) | 53.20B |
| Total Liabilities (Quarterly) | 27.70B |
| Shareholders Equity (Quarterly) | 25.49B |
| Cash from Operations (TTM) | 2.613B |
| Cash from Investing (TTM) | -1.92B |
| Cash from Financing (TTM) | -1.183B |
Ratings
Profile
Edit
| Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Interventional (largely the former Bard business) accounts for 23% of revenue. International revenue accounts for 44% of the company's business. |
| URL | http://www.bd.com |
| Investor Relations URL | https://investors.bd.com/ |
| HQ State/Province | New Jersey |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Equity Style | Large Cap/Blend |
| Next Earnings Release | Nov. 04, 2022 (est.) |
| Last Earnings Release | Aug. 04, 2022 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Sep. 08, 2022 |
Risk Info
Ownership
| Insider Ownership Percentage | Upgrade |
Jul '20
Nov '20
Mar '21
80.00%
40.00%
10.00%
Analyst Coverage
|
Consensus Rating
|
|
|
Analyst Recommendation
|
|
Source: S&P Global
Top Fund Holders
| Symbol | Dollars Invested | % Weight |
|---|---|---|
| JENRX | 422.30M USD | 4.34% |
| IHI | 247.92M USD | 4.22% |
| PRBLX | 1.043B USD | 4.07% |
| PAVLX | 1.224B USD | 3.95% |
| FRDRX | 605.93M USD | 2.49% |
| PACLX | 909.54M USD | 2.00% |
| THQ | 16.97M USD | 1.91% |
| RRFDX | 295.84M USD | 1.74% |
| ZLU.TO | 20.26M USD | 1.40% |
| IYH | 39.97M USD | 1.35% |
| VHT | 244.30M USD | 1.31% |
| FHLC | 34.21M USD | 1.21% |
Other Resources
| Whale Wisdom | 13F Filings |
| Seeking Alpha | Call Transcripts |
| Morningstar | Insider Trading |
| Nasdaq | Institutional Ownership |
| Nasdaq | Option Chain |
| SEC | SEC Filings |
| BDX Tweets |